Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001193125-26-009232

Options or other derivatives

  • Chief Legal Officer acquired 95,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
DiFabio Andrea Chief Legal Officer 2026-01-09 Grant or award · Share Option (Right to Buy) +80,000 80,000 D: show line 1 in the form
DiFabio Andrea Chief Legal Officer 2026-01-09 Grant or award · Restricted Share Units +15,000 15,000 D: show line 2 in the form
Loading xslF345X05/ownership.xml…